Global IoT Technology Ventures, Inc.

About The Fund

Global IoT Technology Ventures, Inc., operating from 1751 River Run, Suite 400, Fort Worth, Texas, is a venture capital fund specializing in a broad range of investment opportunities within the IT (& TMT), Hardware (& Manufacturing), Energy, HealthTech (& Fitness), Material Science, and Robotics industries. With a focus on Equity, they offer financial support across various stages of a company's lifecycle including Seed, Startup, Early Stage, Expansion, and Later Stage ventures, as well as in Management Buyouts and Leveraged Buyouts (MBO/LBO). Their investment thesis revolves around identifying and nurturing advanced biotech in markets in the U.S. that are often overlooked and under-invested, particularly outside the coastal hubs of venture capital activity that dominate Silicon Valley and the Northeastern U.S. They aim to disrupt geographic favoritism by investing in science and innovation regardless of location, targeting the Central U.S. as a key area for discovery and growth. Their portfolio reflects this vision, containing companies like Actuate, Cognition Therapeutics, Encore Vision, and others that are involved in cutting-edge areas such as advanced small molecules, medical devices, engineered cell therapies, digital medicines paired with artificial intelligence, recombinant proteins, and antibodies development. Immusoft Corporation, IN8bio, Lantern Pharma, and Taysha Gene Therapies stand amongst their diversified and technologically-driven investments. The fund prides itself on a combined 80 years of expertise from their team in fields ranging from hedge funds, private equity, clinical drug development to public pharma and biotech analysis, emphasizing their commitment to drive science and company cultivation through their strategic investments.